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Summary
The haploinsufficient tumor suppressor Chk1 is essential for embryonic cells, but the consequences of Chk1 loss in adult
tissues are unknown. Using conditional Chk1 mice, we find that proliferating mammary cells lacking Chk1 undergo apoptosis
leading to developmental defects. Conditional Chk1 heterozygosity increased the number of S phase cells and caused
spontaneous DNA damage. Chk1/ epithelia also exhibit a miscoordinated cell cycle in which S phase cells display an
early mitotic phenotype. These cells maintain high levels of Cdc25A, which can promote inappropriate cell cycle transitions.
Thus, Chk1 heterozygosity results in three distinct haploinsufficient phenotypes that can contribute to tumorigenesis:
inappropriate S phase entry, accumulation of DNA damage during replication, and failure to restrain mitotic entry.
Introduction Chk1 is indispensable in mammals for proper embryogene-
sis (Liu et al., 2000; Takai et al., 2000; Zachos et al., 2003).
Genomic instability is a hallmark of tumorigenesis. Checkpoint Chk1 null mice exhibit embryonic lethality (E6.5) due to a peri-
pathways help maintain genomic stability, and many compo- implantation defect, and this lethality was not rescued in a p53
nents of these pathways are tumor suppressors. The majority null background (Liu et al., 2000; Takai et al., 2000). However,
of tumor suppressors require that both alleles are lost in tumors. the role of Chk1 in adult tissues has not been investigated. This
Chk1 is a tumor suppressor that does not conform to this model. is particularly important because Chk1 has been proposed to
Chk1 is a protein kinase involved in transducing DNA damage be a potential drug target for anticancer therapies (Hapke et
signals and is required for both the intra-S phase and G2/M al., 2001; Li and Zhu, 2002; McKinstry et al., 2002; Zhou et al.,
checkpoints. Tumors observed in germline Chk1/ mice do 2003; Zhou and Sausville, 2003). In order to know whether Chk1
not appear to lose the second allele of Chk1 (Liu et al., 2000), has potential as an antitumor drug target, it is critical that we
suggesting that Chk1 is a haploinsufficient tumor suppressor. understand the consequences of eliminating Chk1 in adult tissues.
However, the molecular mechanisms by which Chk1 heterozy- Alterations in Chk1 may play a critical role in the etiology
gosity may regulate tumor progression are not well understood. of human cancer. For example, genetic mutations for Chk1 have
In response to replicative stress, ATR phosphorylates Chk1 been observed in sporadic, endometrial, and gastrointestinal
at Ser317 and Ser345, which upregulates Chk1 kinase activity tumors displaying microsatellite instability (Bertoni et al., 1999;
Menoyo et al., 2001). Furthermore, LOH at chromosome 11q21-(Liu et al., 2000; Zhao et al., 2002). Activated Chk1 prevents
cell cycle progression by inhibiting the cell cycle phosphatases 24, a region containing several tumor suppressors, including
Chk1, has been observed in a variety of human malignanciesCdc25A and Cdc25C. Chk1-mediated phosphorylation of
Cdc25A results in its degradation, thereby preventing DNA repli- (Gentile et al., 1999; Gudmundsson et al., 1995; Launonen et al.,
1998). Interestingly, the Chk1-regulated oncoprotein Cdc25Acation during exposure to genotoxic agents (Sanchez et al.,
1997; Zhao et al., 2002). These events facilitate the prevention is highly expressed in a multitude of human cancers and is
associated with poor prognosis (Cangi et al., 2000; Dixon et al.,of mitotic entry at the G2 boundary, since Tyr15 of Cdc2 remains
phosphorylated. 1998; Gasparotto et al., 1997; Wu et al., 1998). These results
S I G N I F I C A N C E
DNA replication and damage checkpoints coordinate cellular responses to genotoxic stress. The Chk1 kinase is a key regulator of
both S phase progression and mitotic entry, and has been proposed as a potential antitumor drug target. Here we find that Chk1
is essential for proliferating cell viability in the breast. We describe a novel haploinsufficiency phenotype in Chk1 conditional
heterozygous tissues, which exhibit cells accumulating in an erroneous S phase state with premature localized chromatin condensa-
tion, characteristics commonly found in malignant cells. Accordingly, an increase in LOH at 11q24-25, a region containing the Chk1
locus, has been reported in human tumors. The fact that Chk1 levels are critical for genomic stability and survival of proliferating
cells may limit the usefulness of drugs that inhibit Chk1 as anticancer agents.
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suggest that the loss of Chk1 function may have deleterious
consequences in mammalian cells, possibly due to Cdc25A
deregulation, but this has yet to be demonstrated in an in vivo
animal model.
To investigate the role of Chk1 in adult tissues and to explore
its role in tumorigenesis, we generated a mouse that was condi-
tional for Chk1 in the mammary gland. We found that Chk1 was
essential for mammary epithelial cell growth. However, during
the analysis of these animals, we also observed that Chk1 mice
showed strong phenotypes in a heterozygous background.
Figure 1. WAP-Cre: A developmentally timed mouse mammary glandThese studies demonstrate that Chk1 is haploinsufficient for
model for the conditional deletion of Chk1 kinasecontrol of cell proliferation, genomic stability, and cell cycle
Mice carrying the conditional floxed allele for Chk1 were bred with mam-coordination, and explain its role as a haploinsufficient tumor
mary-specific WAP-Cre mice, generating bigenic animals (WAP-Cre //suppressor.
Chk1/F or F/F ). WAP-Cre is activated in two waves: first, beginning at day
10 of pregnancy (green), Cre will be expressed in 50%–60% of the progenitor
Results mammary epithelial cells (MECs), resulting in the removal of either one (/F )
or both (F/F ) floxed alleles for Chk1, respectively, in these cells. At day 1 of
lactation (yellow), an additional population of 15%–20% of the terminallyHomozygous deletion of Chk1 results
differentiated mammary lobuloalveolar cells in these glands will activatein impaired development
WAP-Cre and delete any conditional alleles for Chk1 in this population. This
To study the role of Chk1 during somatic cell development, we results in the deletion of Chk1 in 65%–80% of the mammary epithelial cells
targeted mice for homozygous disruption of Chk1 in the mouse in this bigenic gland.
mammary gland using a conditional floxed allele. The mammary
gland provides an ideal model in which to study the role of
developmentally essential genes in somatic cells in vivo. The
majority of mammary gland development occurs postnatally; Mammary glands from either WAP-Cre/ // R26R-LacZ/ //
thus, defects arising from the genetic disruption of Chk1 in Chk1 Flox/Flox, /Flox, or wild-type (herein referred to as Chk1
mammary epithelia may affect the ability to nurse young, yet F/F, /F or /) females were removed at day 1 of lactation,
deletion should not impair the general viability of the animal. approximately 11 days after WAP-Cre expression. Detection of
As shown previously, conditional deletion of exon 2 of the Cre-mediated recombination was revealed by -galactosidase
Chk1 gene by Cre recombinase resulted in a null phenotype in staining of L1 trigenic mammary gland wholemounts (Figures 2A
mouse Chk1 FLOX/ embryonic stem cells (Liu et al., 2000). and 2B). Chk1 F/F mammary glands exhibited a dramatic reduc-
Three independent ES cell clones that contained the Chk1/ tion in the number of LMECs as indicated by the decreased
Flox genotype were injected into blastocysts and implanted into numbers of -galactosidase-stained cells (Figure 2A). Impor-
C57BL/6 female mice. In total, 15 chimeric males were obtained. tantly, this decrease in LMECs was proportional to the percent-
When backcrossed to C57BL/6 female mice, four of these chi- age of cells expressing WAP-Cre (50%–60%) during pregnancy,
meras transmitted the targeted allele to their offspring to gener- as previously described. Conversely, trigenic heterozygous
ate the CHK1/FLOX mice (data not shown). (/F ) tissues for Chk1 showed only slightly reduced levels of
The availability of the mammary-specific whey acidic pro- alveolar development, as compared to the wild-type mammary
tein-Cre recombinase (WAP-Cre) transgenic mice facilitated the gland (Figure 2A). Therefore, the Chk1 F/F glands exhibited a
deletion of the conditional Chk1 allele from somatic lobuloal- substantial decrease in the number of LMECs following Cre-
veolar precursor cells in the mammary gland (Wagner et al.,
mediated recombination.
1997a). Cre expression is increased in these transgenic mice
Histological analysis of conditional homozygous Chk1 tissue
at day 10 of pregnancy, when mammary epithelial cells (MECs)
confirmed the marked decrease in the number of Chk1 F/Fare highly proliferative and subsequently undergo differentiation
LMECs, as compared to wild-type (Figure 2B). Quantitation ofinto milk-producing lobuloalveolar mammary epithelial cells
DAPI-stained nuclei in Chk1 /F and F/F tissue sections indi-(LMECs) (Figure 1). However, only approximately 50%–60%
cated a 15%–18% and 55% reduction, respectively, in the num-of the partially differentiating LMEC precursors, during mid-
ber of LMECs present at day 1 of lactation, as compared topregnancy (P10–14), actually express WAP-Cre. In the re-
wild-type. As a result of the substantial loss of milk-producingmaining mammary lobuloalveolar and ductal cells, transgene
LMEC precursors, conditional Chk1 F/F mothers failed to nurseexpression was not observed (Wagner et al., 2002). Further-
their young. Subsequently, the pups of these animals had tomore, during early lactation, e.g., at day 1 of lactation (L1), an
be foster nursed in order for litter survival. In contrast, Chk1additional 10%–15% of fully differentiated LMECs will express
heterozygous animals were able to support their offspring.WAP-Cre, resulting in the generation of a second population of
To examine recombination in the Chk1 F/F glands, PCR-cells activating WAP-Cre (Figure 1). In combination with the
mediated analysis of recombination at the conditional Chk1Flox-Stop-Flox R26R-LacZ (R26R-LacZ) reporter line, Cre ex-
locus was conducted at various intervals during mammary glandpression and recombination in mammary epithelial cells can be
development. DNA was extracted from Chk1 /, /F, andreadily visualized during pregnancy and lactation (Soriano,
F/F mice at days 12 and 16 of pregnancy and day 1 of lactation1999; Wagner et al., 2002). This not only provides a convenient
(2, 4, and 11 days post-Cre activation, respectively). The recom-assay for recombination in the mammary gland, but also facili-
bined Chk1 F/F alleles were detected, at P12, but these LMECstates the analysis of tissue morphology after deleting Chk1 from
epithelial cell precursors. were lost by day 16 (P16, Figure 2C), indicating a lack of recom-
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Figure 2. Conditional deletion of Chk1 from the mammary gland by WAP-Cre results in massive apoptosis and impaired development
A: X-gal stained wholemounts of recombinant bigenic WAP-Cre // Flox-Stop-Flox ROSA lacZ // Chk1 / (a) or recombinant tri-genic WAP-Cre // Flox-
Stop-Flox Rosa LacZ // and either Chk1 /Flox (b) or Chk1 Flox/Flox (c) mammary glands.
B: Hematoxylin and eosin stained sections of X-gal stained WAP-Cre // Chk1 / (a) or trigenic glands for either WAP-Cre // Rosa LacZ // Chk1 /Flox (b)
or Chk1 Flox/Flox alleles (c). Shown at 40 magnification.
C: Schematic for the conditional allele for Chk1 (a); red triangles indicate the two loxP sites flanking Exon 2 of the Chk1 gene; green boxes indicated by
F1 and R2 represent primers designed to detect recombination. b: Upon recombination, exon 2 is deleted, allowing for the detection of recombinant DNA
by PCR using the F1/R2 primer set. c: PCR-mediated recombination yielding a 436 bp product from DNA harvested from WAP-Cre // Chk1 /, /F, or
F/F tissue during days 12 and 16 of pregnancy and day 1 of lactation (approximately 2, 6, and 11 days post-Cre activation, respectively). Genotyping
primers, flanking the 5 loxP site, were used to identify the genotype of the tissue.
D: Terminal transferase TUNEL assays on sections of bigenic day 12 of pregnancy mammary glands from WAP-Cre // Chk1 /, /F, or F/F animals. DAPI
staining (a–d) and TUNEL-positive nuclei (green) are shown for the Dnase-treated control (e), wild-type (f), Chk1 /F tissues (g), and Chk1 F/F (h) samples.
bined cells. Interestingly, the recombinant Chk1 double-floxed detected in WAP-Cre // Chk1 / tissues due to the lack of a
floxed Chk1 allele (Figure 2C). Thus, these results suggestedallele was again detected at day 1 of lactation, coincident with
an additional 15%–20% of the LMECs activating WAP-Cre (Fig- that by day 1 of lactation, homozygous floxed LMECs undergo
apoptosis, and these mice fail to lactate due to the loss of theseures 1 and 2C). In contrast, the levels of recombination in the
Chk1 /F LMECs remained constant during pregnancy and LMEC precursors.
To investigate the possibility of apoptosis during develop-lactation (Figure 2C). As a control, recombination was never
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ment, female conditional Chk1 mice were mated and glands 10 of histone H3, a commonly used mitotic marker. Phospho-
H3 staining was detected in over 30% of the Chk1 /F nuclei,were harvested at pregnancy day 12 (P12), approximately 2
days after WAP-driven Cre expression begins to increase in as large punctate foci at the periphery of the nucleus (Figures
4A and 4C). This level of minor H3 phosphorylation is usuallythese tissues. Sections from these conditional glands were
screened for the presence of apoptotic LMEC progenitors using indicative of cells in late G2 phase of the cell cycle (Crosio et
al., 2002). Unexpectedly, a large majority of the Chk1 /F cells,a terminal transferase-based TUNEL assay. P12 Chk1 F/F mam-
mary glands exhibited substantial apoptosis in approximately which contained phosphorylated H3 staining, also prominently
displayed BrdU incorporation within the same nucleus (Figure10%–12% of differentiating LMECs, while Chk1 conditional het-
erozygotes and wild-type glands demonstrated only 3% and 4A). It is highly unlikely that these Chk1 /F cells could have
entered into late G2/M within the in vivo time frame of BrdU1%, respectively (Figure 2D). This level of progenitor cell apo-
ptosis in the Chk1 F/F mammary gland is sufficient to impair labeling (Christov et al., 1993; Goepfert et al., 2000; Rajan et
al., 1996). In contrast, wild-type glands rarely exhibited boththe normal development of this tissue. Therefore, the deletion of
Chk1 from proliferating somatic cells in vivo results in cell lethality BrdU staining and phospho-H3 accumulation, since these pro-
cesses are normally restricted to S phase and mitosis, respec-mediated by a currently unknown apoptotic mechanism.
tively (Figure 4A). Thus, in vivo analysis of Chk1 heterozygous
tissues revealed not only inappropriate DNA replication, butChk1 is a haploinsufficient tumor suppressor
Since the role of Chk1 is thought to maintain functionally intact also spontaneous partial chromatin condensation prior to the
completion of S phase, which may lead to genomic instabilityDNA replication and G2/M checkpoints, we next examined cell
cycle progression in the mammary glands harvested from day due to the lack of apoptosis observed.
To examine this pattern seen for phosphorylated histone1 lactating WAP-Cre // Chk1 /, /F, or F/F mice. Females
were injected intraperitoneally with BrdU and glands were har- H3 in Chk1 /F glands, tissues were stained for the suspected
histone H3 kinase, Aurora B. A marker for mitotic progression,vested after 2 hr, approximately equal to a 30 min label time
in vivo, to measure the levels of DNA synthesis within these Aurora B kinase was readily observed in wild-type cells prog-
ressing through mitosis (data not shown) (Crosio et al., 2002;tissues (Kriss and Revesz, 1962; Rocha et al., 1990). Wild-type
mammary glands displayed approximately 6.5% BrdU positive Terada et al., 1998). Conversely, Aurora B colocalized exclu-
sively with phospho-H3 to the same large condensed nuclearcells, consistent with previously published reports (Figures 3A
and 3B) (Wagner et al., 1997b). Chk1 F/F samples showed even foci at the nucleoplasmic side of the nuclear membrane in
Chk1 /F LMECs (Figure 4B). Quantitative analysis of the num-lower levels of proliferation at approximately 4%, presumably
due to the apoptosis of previously replicating cells (Figures ber of cells demonstrating Aurora B or phospho-H3 costaining
revealed an approximately 1:1 ratio (Figures 4B and 4C), consis-3A and 3B). Strikingly, in Chk1 heterozygous tissues, a 6-fold
increase (35%) in the number of BrdU-stained cells was de- tent with the90% colocalization observed. INCENP, the chro-
mosomal passenger protein necessary for Aurora B activity dur-tected, as compared to wild-type mammary glands (Figures 3A
and 3B). This haploinsufficiency defect has not been previously ing mitosis, also colocalized to these large discrete foci (data
not shown). Although Aurora B and INCENP have a conservedreported in mammalian cell culture using Chk1-specific siRNAs.
To explore this phenomenon, sections were costained for role for inducing chromatin condensation during mitosis, these
cells still fail to fully condense their DNA, as only 6% of theseBrdU incorporation and an antibody that recognizes phosphory-
lated Thr187 on the Cdk inhibitor, p27. The phosphorylation of Chk1/F nuclei proceeded to accumulate phospho-histone H3
staining characteristic of a mitotic cell. These data suggest thatp27 at this particular threonine marks the G1/S transition in
mammalian cells. A feedback loop is created since Cdk2/cycE due to Chk1 haploinsufficiency, these cells display a miscoordi-
nated cell cycle marked by premature chromatin condensationphosphorylates p27 at T187, targeting it for destruction. Upon
staining, Chk1 wild-type samples could be divided into three prior to completion of DNA synthesis.
Further evidence of miscoordination comes from costainingpopulations: those that are in late G1 represented by only phos-
pho-p27, those nuclei in mid-late S phase, marked by only of phospho-p27 (late G1) and Aurora B (mitosis) in Chk1 hetero-
zygotes. We observed coexpression of these two markers inBrdU, or those proliferating cells which have exited late G1 and
have entered early S signified by the staining of both markers approximately 25%–30% of 1000 epithelia quantitated (Supple-
mental Figure S1A at http://www.cancercell.org/cgi/content/(Figures 3A and 3C). The specificity of this antibody was vali-
dated by the absence of detectable staining in p27/ mam- full/6/1/45/DC1). This is in contrast to wild-type tissues, which
showed1% coexpression (Supplemental Figure S1A). In addi-mary epithelium (Figure 3A). Chk1 heterozygous LMECs promi-
nently displayed a 10-fold increase in the number of nuclei tion to the BrdU/p-H3 phenotype above, these data further
support a state of cell cycle miscoordination in Chk1 conditionalwith phospho-p27 (late G1) staining as compared to wild-type
(Figures 3A and 3C). Approximately 85% of the nuclei exhibiting heterozygotes.
BrdU incorporation also costained for phospho-p27 Thr187, indi-
Cdc25A accumulates in Chk1 heterozygous tissuescating that these cells are in a stage with active Cdks. It is possible
The oncoprotein Cdc25A phosphatase is involved in the activa-that phosphor-p27 T187 causes conditionally Chk1 /F cells to
tion of Cdk2/CycE at the G1/S transition and facilitates activa-exit G1, resulting in substantially increased rates of DNA syn-
tion of DNA replication. Since Chk1 has been implicated inthesis.
the negative regulation of Cdc25A (Sorensen et al., 2003), we
examined Cdc25A protein levels in whole tissue lysates fromHaploinsufficiency causes partial chromatin
condensation during S phase day 1 lactating heterozygous Chk1 glands by Western blotting.
A marked increase in the total amount of Cdc25A protein wasTo ascertain whether Chk1 /F cells are cycling through to
mitosis, tissue sections were stained for phosphorylated serine observed in heterozygous Chk1 lysates compared to wild-type
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Figure 3. Chk1 heterozygosity in somatic LMECs results in increased numbers of cells in S phase
A: BrdU was injected 2 hr prior to biopsy from Chk1 / (a–d), Chk1 F/F (e–h), or Chk1 /F (i–l) mammary glands at day 1 of lactation (all tissues carried
the WAP-Cre transgene). Paraffin-embedded glands were stained with DAPI (a, e, and i), anti-BrdU-FITC (b, f, and j), or anti-phospho-p27 T187 (Texas
Red, c, g, and k). Merged images are shown (d, h, and l). Scale bars represent 50 m. Arrows indicate BrdU only (red), phospho-p27 only (yellow), or both
phospho-p27 and BrdU (white) stained nuclei. m and n represent the negative control for the phospho-p27 Ab by staining p27/ tissues.
B: Lysates generated from day 1 lactating WAP-Cre // Chk1 /, WAP-Cre // Chk1 /F, WAP-Cre // Chk1 F/F, or Chk1 F/F mammary glands were
electrophoresed on SDS-PAGE gels, and Western analysis was carried out using a monoclonal antibody against Chk1.  actin blotting is shown as a loading
control. Bands were quantitated using Image QuaNT software. Normalization is shown in terms of percentages of the CHK1/ actin ratio compared to
WAP-Cre // Chk1 / (100%).
C: Epithelial cells from tissue sections were counted and the percentage of nuclei with BrdU incorporation are shown for the labeled WAP-Cre // Chk1
genotypes (a). Graph representing the total percentage of cells marked by either phospho-p27 only (late G1), phospho-p27  BrdU (early S phase), or
BrdU only (mid-late S phase) in WAP-Cre // Chk1 / or /F tissue sections (b).
D: Lysates generated from day 1 lactating WAP-Cre // Chk1 / or /F mammary glands were electrophoresed on SDS-PAGE gels and Western analysis
was carried out using a monoclonal anti-Cdc25A antibody.  actin blotting is shown as a loading control.
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Figure 4. Chk1 heterozygosity results in cell cycle miscoordination
A: Sections of either WAP-Cre // Chk1 / (a–d) or WAP-Cre // Chk1 /F (e–h) were stained with anti-phosphorylated histone-H3 Ser10 (Texas Red, b and f)
or anti-BrdU-FITC (c and g). Representative merged images are shown in d and h. Scale bars represent 10 m. Red arrows indicate representative nuclei.
B: Sections of either WAP-Cre // Chk1 / (a–d) or WAP-Cre // Chk1 /F (e–h) were stained with anti-phosphorylated histone-H3 Ser10 (Texas Red, b and f)
and anti-Aurora B antibodies (c and g). Merged images are shown (d and h). Scale bars represent 10 m.
C: Epithelial cells from tissue sections were counted each for WAP-Cre // Chk1 / or Chk1 /F samples, and the percentage of nuclei demonstrating 3
large nuclear foci for phospho-H3 or Aurora B is displayed.
extracts (Figure 3D). This suggests that an inadequate level of and without Cre), /F, and / glands. We observed a 45%
reduction in Chk1 protein in heterozygotes in Western blots, asChk1 kinase activity exists in vivo to properly regulate Cdc25A
protein levels. To directly examine Chk1 deficiency, we mea- compared to wild-type lysates (Figure 3B). Thus, Chk1 levels
appear to be reduced by approximately one half in conditionalsured Chk1 protein levels in tissue lysates from Chk1 F/F (with
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Figure 5. Heterozygous Chk1 cells are in early S phase
A: WAP-Cre // Chk1 / and WAP-Cre // Chk1 /F tissues were stained with anti-pericentrin (b and e). Blue represents DAPI-stained DNA (a and d). Red
arrows indicate either 1 or 2 centrosomes (red). Merged images are shown in c and f). Scale bar indicates 1 m.
B: Tissues from A were stained with CREST autoimmune sera specific for centromeres (green, c, g, and k). BrdU incorporation is indicated in red (b and f).
Merged images are shown in d, h, and l. DAPI-stained DNA is shown in a, e, and i. Red arrows indicate unduplicated centromeres. A representative G2/M
NIH 3T3 cell stained for phospho-H3 (red, j) and CREST is shown. White arrows indicate duplicated centromeres. Scale bar indicates 5 (a–h) and 1 (i–l) m.
heterozygotes, which explains the haploinsufficient phenotype. DNA replication markers indicate early-mid S phase
Phospho-p27/BrdU and phospho-H3/Aurora B staining shouldThe high levels of Cdc25A and the reduced level of Chk1 in
Chk1/F tissues, in conjunction with the increased percentages reflect two mutually exclusive stages of the cell cycle, early
S and G2/M, respectively. Yet these markers appeared to beof cells undergoing DNA replication and premature chromatin
condensation, help delineate a critical interaction between Chk1 coexpressed in LMECs heterozygous for Chk1. Thus, it was
important to utilize other independent markers to ascertain theand Cdc25A in regulating proper G1 exit and S phase entry.
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correct stage of cell cycle in these LMECs. Accordingly, we Chk1 LMECs appear to accumulate endogenous DNA damage.
stained Chk1 /F tissues for pericentrin, a peripheral centroso- The foci formation observed by DNA repair proteins suggest
mal marker, which should indicate whether these cells were in that these Chk1/F LMECs are undergoing an aberrant S phase
early S or G2 depending upon the number of centrosomes resulting in spontaneous DNA damage, in vivo, at day 1 of
displayed. In wild-type tissues, we detected some cells in G2 lactation.
represented by the presence of two centrosomes (Figure 5A). In To confirm that heterozygosity for Chk1 is inducing the DNA
contrast, Chk1 /F LMECs displayed only a single centrosome damage observed in the conditional heterozygotes, germline
along with the characteristic peripheral chromatin condensation Chk1/ mammary glands without WAP-Cre were stained for
mentioned previously (Figure 5A, for quantitation see Supple- these same checkpoint related proteins. As expected, 53BP1
mental Data). These data indicate that these Chk1 heterozygous (Figure 6A) and MDC1 (Figure 6B) each exhibited increased
cells have not yet replicated their centrosomes, suggesting a levels of DNA damage foci formation relative to wild-type tissues
cell cycle period prior to G2. (Figure 6D). Interestingly, germline heterozygotes (/null) dis-
As centromeres are the last segment of chromosomes to played fewer total nuclei, which stained for these particular
duplicate during DNA replication, we examined them to confirm markers, than their Chk1 conditional heterozygous counter-
that these cells were in early S phase, as suggested by the parts, suggesting the possibility that some precursors for these
results of the phosho-p27 staining. The autoimmune sera from cells were selected against earlier in development in the absence
scleroderma CREST patients has widely been used to stain for of wild-type levels of Chk1 (Figure 6D).
centromeres in mammalian cells (Brenner et al., 1981; Moroi et
al., 1980). If cells in S phase have yet to duplicate their centro-
Homozygous Chk1 progenitor cells exhibit
meres during DNA replication, then early S phase mouse nuclei
the haploinsufficient phenotypewith 20 chromosomes should only exhibit twenty individual cen-
To ascertain whether conditional Chk1 F/F homozygous LMECtromeric foci (Figure 5B and Supplemental Figure S1). In con-
progenitors also displayed a similar phenotype, mammarytrast, the centromere number will double to 40 centromeres
glands from day 12–12.5 of pregnancy, 2–2.5 days post Cre(indicated by 20 paired sister chromatid doublets) if such cells
activation, were harvested from Chk1 / and Chk1 F/F fe-progress through late S phase and into G2 (NIH3T3, Figure 5B).
males and stained for BrdU and phospho-H3. Indeed, Chk1 F/FChk1 heterozygous tissues costained for both BrdU incorpora-
cells displayed cell cycle anomalies (Figure 7A) very similar totion and centromeres (CREST) displayed only single centro-
those of Chk1 /F LMECs at lactation (Figure 4A). In contrast,meres while exhibiting DNA synthesis, confirming that they exist
wild-type tissues properly displayed S phase staining separatelyin a stage before late S phase (Supplemental Figure S1). These
from those nuclei undergoing mitosis (Figure 7A).results indicate that these Chk1 heterozygous cells are in early-
Additionally, Chk1 F/F tissues at P12–P12.5 were stainedmid S phase and display a miscoordinated cell cycle by concur-
for DNA damage markers to provide an explanation for therently exhibiting mitotic markers.
apoptosis observed in Figure 2D and the subsequent failure in
development. In correlation with the cell cycle miscoordination,Chk1 haploinsufficiency causes DNA damage
Due to the large number of cells undergoing inappropriate DNA MDC1 and phospho-H2A.X DNA damage foci were observed in
replication while prematurely condensing their chromatin, we approximately 10% of Chk1 F/F nuclei (Figure 7B). Importantly,
sought to ascertain whether these Chk1/F LMECs were expe- nuclei with highly saturated phospho-H2A.X staining patterns
riencing spontaneous endogenous DNA damage. To address were particularly striking (Figure 7B, top arrow). Strong H2A.X
this, tissue sections were stained for DNA damage response phosphorylation following apoptotic DNA fragmentation has
proteins using indirect immunofluorescence with antibodies been previously reported (Rogakou et al., 2000). As such, the
against mouse 53BP1 (Figure 6A), MDC1 (Figure 6B), and phos- elevated levels of phosphorylated H2A.X in homozygous Chk1
pho-H2A.X (Figure 6C). A hallmark of many proteins involved cells may be a result of the DNA fragmentation seen during
in DNA repair is their ability to form nuclear foci in response to programmed cell death.
DNA damage. The appearance of punctate nuclear foci, without
the addition of any exogenous DNA damaging agents (note: the Aurora B is temporally mislocalized
Chk1/ and/F mice were all expressing Cre recombinase— To verify whether Aurora B sequestration only occurred in those
see Discussion) were quantitatively scored for each individually cells that were experiencing a DNA damage response in vivo,
stained DNA damage protein. tissue sections were costained with antibodies against Aurora
This analysis revealed that a significant number of heterozy- B and MDC1. The pattern of immunofluorescence demonstrated
gous LMECs were undergoing a DNA damage response in Chk1 that the large distinct foci for Aurora B only localized to con-
conditional heterozygotes. The occurrence of multiple (6) DNA densed chromatin in those Chk1 heterozygous cells undergoing
damage foci per nuclei were seen in 36%–38% of the cells
a DNA damage response. These nuclei were marked by punc-across the mammary glands of Chk1 /F mice (Figure 6D). All
tate foci formed by both MDC1 and Aurora B (Figure 8A). It isthe checkpoint markers used (MDC1, 53BP1, p-H2A.X) closely
important to note that Aurora B did not colocalize with MDC1.correlated with one another (	2%) in terms of the total number
Note that in wild-type tissues, Aurora B was also visualized atof cells forming DNA damage foci (Figure 6D). In contrast, wild-
the periphery of nuclei undergoing a DNA damage response,type LMECs displayed foci in less than 6.5% of those cells
albeit at levels far lower than heterozygous cells (Figure 8A).stained for damage response proteins (Figure 6D). The recently
Closer examination of the large Aurora B foci revealed thatpublished colocalization of MDC1 with phosphorylated H2AX, a
the heterochromatin in these areas appeared to be condensedvariant of histone H2A, was also observed in these heterozygous
into large discrete foci represented by increased DAPI absorp-Chk1 LMECs (Figure 6C) (Schultz et al., 2000; Stewart et al.,
tion (Figure 8A). Aurora B colocalized with these large peripheral2003). Since the phosphorylation of H2A.X is thought to only
occur during a DNA damage response, these heterozygous condensed DAPI foci (Figure 8A). This is reminiscent of nuclei
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Figure 6. Chk1 heterozygous LMECS exhibit endogenous DNA damage
A and B: WAP-Cre // Chk1 / (a and d), WAP-Cre // Chk1 /F (b and e), or germline Chk1/ lacking WAP-Cre (c and f) mammary glands were
sectioned and stained (green) against either anti-53BP1 (A) or anti-MDC1 (B). Arrows indicate representative nuclei with endogenous DNA damage foci.
Scale bars represent 10 m.
C: WAP-Cre // Chk1 / (a–d) or WAP-Cre // Chk1 /F (e–h) nuclei were costained using antibodies against phospho-H2A.X (b and f) and MDC1 (c
and g). Merged images for the two panels are shown in d and h. Red arrows indicate representative endogenous nuclear DNA damage foci. Scale bars
represent 1 m.
D: Quantitation of the total percentage of mammary lobuloalveolar epithelium displaying6 foci/nuclei when staining for 53BP1 (a), MDC1 (b), or phospho-
H2A.X (c) in tissue sections presented in A–C.
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Figure 7. Following recombination, Chk1 F/F tissues reveal cell cycle miscoordination
A: Sections of either WAP-Cre // Chk1 / (a–d) or WAP-Cre // Chk1 F/F (e–h) were stained with anti-phosphorylated histone-H3 Ser10 (Texas Red, b and f)
or anti-BrdU-FITC (c and g). Representative merged images are shown in d and h. Scale bars represent 10 m. Red arrows indicate representative nuclei.
B: WAP-Cre // Chk1 / (a–d) or WAP-Cre // Chk1 F/F (e–h) nuclei were costained using antibodies against phospho-H2A.X (b and f) and MDC1 (c and g).
Merged images for the two panels are shown in d and h. Red arrows indicate representative nuclei. Scale bars represent 10 m.
which undergo premature chromatin condensation (PCC) in re- and homozygous somatic cells in breast tissue. We present
evidence that the Chk1 regulated oncoprotein Cdc25A accumu-sponse to hydroxyurea or other agents, which cause DNA dam-
age, leading to an activated DNA damage checkpoint response lates in Chk1 heterozygous tissues. The lobuloalveolar mammary
epithelial cells (LMECs) from conditional Chk1 mice demonstrated(Nghiem et al., 2001). The DAPI staining of Chk1 heterozygous
cells appeared to be concentrated in large discrete darkly distinct but striking phenotypes depending on the disruption of
one or both alleles for Chk1 and demonstrate an important rolestained regions analogous to previous descriptions of cells un-
dergoing premature chromatin condensation. These results for Chk1 in maintaining the genomic integrity of developing
somatic tissues.suggest that during a mammalian DNA damage checkpoint re-
sponse, Aurora B kinase may be sequestered to partially con-
densed regions of chromatin. Chk1 deletion results in cell lethality
The initial phenotype observed in Chk1 homozygous floxed mice
was a failure of mothers to nurse their young. This lactogenicDiscussion
defect was caused by a rapid wave of apoptosis in the LMEC
precursor population during mid-pregnancy (P10–P14), onceIn contrast to previous studies that focused primarily on cell
culture or early embryogenesis experiments, in this study, we Chk1 was deleted. These results correlate with previous studies
using conditional Chk1 ES cells treated with Adeno-Cre recom-define the in vivo phenotype of conditional Chk1 heterozygous
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Figure 8. Aurora B is localized to foci of condensed chromatin in cells experiencing DNA damage
A: Sections of WAP-Cre // Chk1 / (a–c) or WAP-Cre // Chk1 /F (d–f) mammary glands were costained with anti-MDC1 (green) and anti-Aurora B
(Texas Red). Merged images for DAPI (blue) with MDC1 and Aurora B are shown (c and f). White arrows represent nuclei containing DAPI and Aurora B
foci indicative of condensed chromatin (pink). Scale bars represent 10 m.
B: A model for the consequences of Chk1 heterozygosity. Deletion of a single Chk1 allele results in the disruption of ordered cell cycle events. These cells
exhibit an increase in p27 phosphorylation facilitating entry into S phase. As a result of unscheduled DNA synthesis and Chk1 haploinsufficiency, DNA
damage accumulates, probably due to an inability to detect and repair replicative lesions. Cell cycle miscoordination occurs in part due to inappropriate
Cdc25 activity leading to activation of Cdks at the G1/S and G2/M boundaries. In addition, compromised G2/M checkpoint activation led to partial
chromatin condensation and Aurora B kinase sequestration. Dotted lines indicate partially defective regulation.
binase, which also exhibited high levels of apoptosis within synthesis, which we feel are likely to require Chk1 function for
survival. This explains the appearance of recombinant -galac-36–48 hr postinfection (Liu et al., 2000). However, the 10%–20%
of LMECs that lost Chk1 during Cre activation, at day 1 of tosidase-stained cells at day 1 of lactation in Chk1 F/F tissues.
In support of this hypothesis, TUNEL analysis in Chk1 F/F tis-lactation, do not undergo apoptosis, suggesting it is not com-
pletely essential. How can this be explained? These lactating sues did not reveal any increased levels of apoptosis over wild-
type tissues at day 1 of lactation (data not shown).LMECs are terminally differentiated cells, and as such they do
not undergo cellular proliferation (Wagner et al., 2002). Due to
this nonproliferative state, they do not exhibit the apoptotic cell Chk1 heterozygosity causes an abnormal cell cycle
In contrast to Chk1 null mammary glands, Chk1 /F glandsdeath observed in the mid-pregnant LMEC precursors, since
they do not incur replicative stresses from undergoing DNA after Cre expression were apparently functional with respect to
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tissue function. However, these heterozygous LMECs exhibited in nonconditional heterozygous Chk1 mice, which do not ex-
an enhanced propensity to undergo DNA synthesis, while simul- press Cre. Thus, the haploinsufficiency observed here suggests
taneously undergoing other cell cycle events that normally do that physiological Chk1 protein levels play a critical role in the
not coincide with S phase. For example, Chk1 /F LMECs regulation of DNA replication (Feijoo et al., 2001; Lee et al.,
immunostained for both p27 T187 phosphorylation and BrdU 2003).
incorporation revealed that greater than 30% of these cells had
exited late G1 and subsequently entered an S phase-like state, Chk1 shows haploinsufficiency for prevention
distinct from the Chk1 / controls. In addition, Chk1 /F of premature mitosis
LMECs appear to experience DNA damage during this S phase Previous studies revealed that increased levels of Cdc25A are
state as indicated by the number of damage foci detected. sufficient to override the restraint of mitotic entry during S phase,
Interestingly, these cells accumulate Aurora B at large foci local- resulting in premature chromatin condensation (Molinari et al.,
ized to the nucleoplasmic side of the nucleus, and these foci 2000). Moreover, Cdc25A has been shown to play a significant
colocalized with phosphorylated histone H3 at Ser10, indicative role in activating Cdc2/cycB during mitosis (Mailand et al.,
of DNA condensation at these areas typical of late G2. Although 2000). Due to the increased levels of Cdc25A observed in Chk1
the expression of these two markers suggests that the Chk1 heterozygotes, the localized chromatin condensation observed
heterozygous cells are in G2/M, the analysis of centrosomal may be a result of premature activation of Cdc2/cycB complexes
(pericentrin) and centromeric (CREST) markers indicates a time during S phase. Active Cdc2/cycB complexes inhibit protein
frame during early S phase, since these cells have not under- phosphatase 1, which is an event necessary for the activation
gone centrosome duplication, nor have they fully completed of Aurora B during mitosis (Goto et al., 2002; Murnion et al.,
one full round of DNA synthesis by replicating their centromeres. 2001; Sugiyama et al., 2002). Since the expression of a non-
Our findings suggest a possible role for Chk1 in control of phosphorylatable Cdc2 Y15A mutant in human cells induced
the G1/S transition. Chk1 heterozygous cells show an inappro- premature chromatin condensation (Jin et al., 1996), it appears
priately high number of LMECs incorporating BrdU, suggesting plausible that the chromatin condensation observed in Chk1
an inappropriate number of these cells traversing S phase (Fig- heterozygotes and the localization of Aurora B to these struc-
ure 8B). Formally, in an animal model such as this, we cannot tures is a result of at least partial activation of Cdc2, possibly
distinguish between inappropriate G1 exit versus a slowing through inappropriate Cdc25A activation (Figure 8B).
down of cells during S phase as an explanation for this increase.
All of the phenotypes observed in the heterozygous animals
However, Chk1 heterozygous cells have increased levels of
are also observed in the homozygous nulls. The difference is
Cdc25A, and it has been previously shown that overexpression
that the homozygous null cells all appear to undergo apoptosis,of Cdc25A can accelerate the G1/S transition via the premature
indicating that their cellular defects are significantly more se-activation of cyclin E- and cyclin A-dependent kinases (Blom-
vere. Mammalian Chk1 appears to perform a similar functionberg and Hoffmann, 1999; Molinari et al., 2000; Vigo et al.,
to the budding yeast Chk2 homolog, Rad53, which also has an1999). Thus, we favor the explanation that cells are inappropri-
important role in stabilizing stalled replication forks and recov-ately exiting G1. This is consistent with the observation that
ering from replicative stress (Sogo et al., 2002; Desany et al.,these cells also show increased levels of phospho-T187 p27,
1998). It is likely that in Chk1 F/F cells, the inability to resolvewhich is typically observed in late G1-early S phase nuclei com-
defective replication structures coupled with miscoordinationmitted to DNA synthesis. Cdk2/cycE activity has been proposed
of cell cycle and inappropriate mitotic entry is responsible forto regulate this phosphorylation of p27 (Sheaff et al., 1997),
the induced apoptosis.which could be caused by Cdc25A overproduction. However,
Our current data support a model in which haploinsuffi-once S phase entry has occurred, a prolonged S phase may
ciency in Chk1 heterozygotes can result in three distinct haploin-also result as a consequence to unresolved replication stress.
sufficient phenotypes that each can contribute to tumorigenesis:As such, these results suggest a possibly indirect role for Chk1
inappropriate entry into S phase, accumulation of DNA damagein regulating the G1/S transition through its direct control of
during replication, and a failure to restrain mitotic entry in theCdc25A protein levels.
presence of a damaged S phase. These results explain Chk1’s
role as a haploinsufficient tumor suppressor and suggest thatChk1 /F tissues experience a damaged S phase
inactivation of a single allele of Chk1 in human tumors by muta-Previous studies have demonstrated that Chk1 is essential for
tion, chromosomal deletion, or epigenetic silencing may be ahalting replication origin firing in response to DNA damage (Fei-
common source of genomic instability driving tumorigenesis.joo et al., 2001). In addition, chicken tumor cells engineered to
Chk1 has been proposed to be a potential drug target forlack Chk1 fail to maintain viable replication forks or suppress
anticancer therapies (Hapke et al., 2001; Li and Zhu, 2002;futile origin firing when DNA polymerase is inhibited, leading to
McKinstry et al., 2002; Zhou and Sausville, 2003; Zhou et al.,incomplete genome duplication and diminished cell survival
2003). However, our studies suggest that Chk1 is essential forafter release from replication arrest (Zachos et al., 2003). Chk1
adult proliferating cells. As death of nontumor proliferating cellsis therefore a critical responder to DNA replicational stress.
limits the usefulness of many current chemotherapeutic treat-Haploinsufficiency for this function would be expected to lead
ments, it is likely that Chk1 inhibition might also have pro-to an inability to properly repair replication problems, resulting
nounced toxicity that may limit its effectiveness in this respect.in the accumulation of damage at replication structures. Hence,
Whether tumor cells will prove more or less resistant to loss ofthe appearance of DNA damage foci containing MDC1, 53BP1,
Chk1 function than wild-type cells remains to be determinedand phospho-H2A.X proteins in Chk1 /F LMECs supports
and will be critical for the success of checkpoint pathway inter-the presence of spontaneous DNA damage in these cells. This
damage is not due to Cre expression, because it is also observed vention as an anticancer strategy.
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Experimental procedures in sections using a mouse monoclonal anti-Aurora B/AIM-1 antibody, 1:200
(Transduction Labs). Mouse INCENP was detected in sections using a rabbit
polyclonal antibody, 1:200 (a generous gift from Dr. William Earnshaw).Generation of conditional Chk1 mice
The Flox targeting vector (pQL456) was constructed as follows: the loxP-neo- Visualization of mitosis was done with a rabbit anti-phospho-S10 Histone
H3 antibody, 1:200 (Upstate). DNA damage foci were detected using rabbitloxP cassette was ligated to a 2.2 kb exon 2-containing genomic fragment, of
which the last 59 bp was replaced by an EcoRV and a loxP site. The loxP- polyclonal antibodies against 53BP1, 1:200 (a gift from Dr. Phil Carpenter),
MDC1 1:200 (Elledge Lab), and a mouse monoclonal phospho-Ser139 H2A.Xneo-loxP-E2-Rv-loxP centerpiece was flanked by 1.9 kb of 5 untranslated
region and 4.3 kb of 3 genomic sequence carrying exons 3–5 (Liu et al., antibody, 1:200 (Upstate). Mouse monoclonal pericentrin antibodies were
obtained from Pharmingen (1:500). The CREST auto-immune serum was a2000). The Chk1 /Flox ES cells was created by targeting one Chk1 allele
with linearized pQL456 vector followed by the excision of the neo marker kind gift from Dr. William Brinkley (1:500). Indirect immunofluorescent detec-
tion was conducted using secondary antibodies obtained from Molecularby transient expression of Cre recombinase. Three Chk1 /Flox ES clones
Probes at 1:200 dilution. Images were captured on a Zeiss/Applied Precisionwere injected into blastocysts to generate chimera, of which two produced
SoftWoRx Image Restoration Microscope (deconvolution) and processedgermline transmission.
using Adobe Photoshop or SoftWoRx proprietary software, respectively.Trigenic mice were generated by mating the mammary-specific WAP-
Cre line (Henninghausen through NCI Frederick) with conditional floxed allele
Chk1 animals. Concurrent mating of Flox Stop Flox Rosa LacZ mice (R26R) Tissue homogenization and Western blotting
As described previously (Said and Medina, 1995), tissue biopsies (approxi-with either the conditional Chk1 or the WAP-Cre animals, was done to
efficiently breed trigenic litters. Genotyping, by PCR, was conducted on mately 0.5 grams) of lactating mammary glands from Chk1 / and /F
animals were directly homogenized in lysis buffer (Said and Medina, 1995)mouse tail DNA using specific primers designed against WAP-Cre (Wagner
et al., 1997a) or LacZ (Rijnkels and Rosen, 2001). We designed the Chk1 with the appropriate protease inhibitor cocktail (Roche). Protein analysis,
electrophoresis, and blotting followed standard protocols. Mouse mono-F1 (5-ACC TGC CCG CAA CTC CCT TTC-3) and R1 (5-CCA TGA CTC
CAA GCA CAG CGA-3) genotyping primers to flank the 5 LoxP site of the clonal Cdc25A (Santa Cruz) and rabbit polyclonal  actin antibody (Cell
Signal) antibodies were used at 1:1000 in PBST.conditional mouse Chk1 allele. This yielded a 380 bp PCR product for the
conditional allele in comparison to a 318 bp product for the wild-type allele
(54
C for 35 cycles). The presence of the Chk1 null allele was confirmed by Acknowledgments
using a primer set against the neomycin gene of the following sequence,
NeoF (5-GAT CGG CCA TTG AAC AAG ATG G-3) and NeoR (5-CCT GAT We would like to thank William Earnshaw and Phil Carpenter for providing
GCT CTT CGT CCA GAT C-3), respectively. the anti-INCENP and 53BP1 antibodies. Our gratitude goes to Monique
Rijnkels for support with the R26R lacZ reporter mice and Philip Soriano for
originally providing these mice, Bin Wang for help with the conditional Chk1Mammary gland biopsy and histological analysis
animals, and Thenaa Said for her assistance with the phospho-p27 cellInguinal mammary glands were harvested at day 1 of lactation from mice
cycle analysis. Our appreciation goes out to Sandy Grimm for providing thewho had given birth within the last 4–8 hr. Glands were fixed in 4% paraform-
negative control for the phospho-p27 Ab. S.J.E. is an investigator with thealdehyde for either a 2 hr fixation period for immunocytochemistry and
Howard Hughes Medical Institute and is supported by grants from the NIHTUNEL analysis or 4 hr for histology. Tissues were then paraffin embedded
and DOD. This work was mainly supported by an NIH CA grant, awardedand 5 m sections were then cut and placed on glass slides. X-Gal staining
to J.M.R.of mammary gland tissue was incubated O/N at 37
C in X-gal staining buffer
following 1.5–2 hr fixation in 4% paraformaldehyde as previously described
(Rijnkels and Rosen, 2001). H&E staining of sections from whole-mounted,
paraffin embedded tissues followed standard histological protocols. Whole
mounts of day 1 of lactation mammary glands stained with X-Gal were taken Received: December 2, 2003
on a Leica MZ FLUOIII stereomicroscope. Images for the X-gal and H&E Revised: April 29, 2004
staining on mammary gland sections were taken on an Olympus BX41 Accepted: May 21, 2004
system microscope and processed with Adobe Photoshop. Published: July 19, 2004
TUNEL and PCR recombination analyses References
Inguinal mammary glands from day 12 of pregnancy were harvested and
fixed, as described above. Sections were then deparaffinized and rehy-
Bertoni, F., Codegoni, A.M., Furlan, D., Tibiletti, M.G., Capella, C., and Brog-
drated. Following 15 min of antigen retrieval in 10 mM sodium citrate, the gini, M. (1999). CHK1 frameshift mutations in genetically unstable colorectal
slides were then cooled and washed 4  3 min in ddH2O and then once and endometrial cancers. Genes Chromosomes Cancer 26, 176–180.
for 3 min in PBS. The protocol for the TdT terminal transferase kit was then
Blomberg, I., and Hoffmann, I. (1999). Ectopic expression of Cdc25A acceler-followed (Roche and ChromaTide dUTP, Molecular Probes). Sections were
ates the G(1)/S transition and leads to premature activation of cyclin E- andthen mounted with Vectashield with DAPI (Vector Labs). For PCR-based
cyclin A-dependent kinases. Mol. Cell. Biol. 19, 6183–6194.analysis of recombination in Chk1 /F and F/F tissues, DNA was extracted
from 5 M sections from 3–5 separate single parous mouse mammary Brenner, S., Pepper, D., Berns, M.W., Tan, E., and Brinkley, B.R. (1981).
glands of such genotype. Recombinant DNA was detected using the forward Kinetochore structure, duplication, and distribution in mammalian cells: anal-
genotyping primer Chk1 F1 and a reverse primer Chk1 R2 (5-TGC AAC AGC ysis by human autoantibodies from scleroderma patients. J. Cell Biol. 91,
TTC TTC AGT TAT TC-3). Using 200 ng of genomic DNA, a recombinant 436 95–102.
bp band representing the recombined Chk1 allele could be detected using
Cangi, M.G., Cukor, B., Soung, P., Signoretti, S., Moreira, G., Jr., Ranashinge,the Expand High Fidelity PCR system (Roche) at 50
C for 40 cycles in a
M., Cady, B., Pagano, M., and Loda, M. (2000). Role of the Cdc25A phospha-Perkin Elmer thermocycler.
tase in human breast cancer. J. Clin. Invest. 106, 753–761.
Immunofluorescence microscopy and antibodies Christov, K., Swanson, S.M., Guzman, R.C., Thordarson, G., Jin, E., Tala-
Immunofluorescent staining of mammary gland tissue was as follows: sec- mantes, F., and Nandi, S. (1993). Kinetics of mammary epithelial cell prolifera-
tions were prepared as described for TUNEL analysis until the PBS step. tion in pituitary isografted BALB/c mice. Carcinogenesis 14, 2019–2025.
Sections were then blocked with goat serum (Sigma) 1:100 in blocking
Crosio, C., Fimia, G.M., Loury, R., Kimura, M., Okano, Y., Zhou, H., Sen,solution (3% BSA and 0.1% Tween 20 in PBS [pH 7.4]) for 1 hr. Specific
S., Allis, C.D., and Sassone-Corsi, P. (2002). Mitotic phosphorylation ofprimary antibodies were then added at the appropriate dilution in blocking
histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol.
buffer and then incubated overnight at RT in a humidified chamber. BrdU Cell. Biol. 22, 874–885.
analyses were conducted using a mouse monoclonal anti-BrdU antibody
conjugated to FITC (Becton Dickinson) (1:5). Mouse Aurora B was detected Desany, B.A., Alcasabas, A.A., Bachant, J.B., and Elledge, S.J. (1998). Re-
CANCER CELL : JULY 2004 57
A R T I C L E
covery from DNA replicational stress is the essential function of the S phase Autoantibody to centromere (kinetochore) in scleroderma sera. Proc. Natl.
Acad. Sci. USA 77, 1627–1631.checkpoint pathway. Genes Dev. 12, 2956–2970.
Dixon, D., Moyana, T., and King, M.J. (1998). Elevated expression of the Murnion, M.E., Adams, R.R., Callister, D.M., Allis, C.D., Earnshaw, W.C.,
and Swedlow, J.R. (2001). Chromatin-associated protein phosphatase 1cdc25A protein phosphatase in colon cancer. Exp. Cell Res. 240, 236–243.
regulates aurora-B and histone H3 phosphorylation. J. Biol. Chem. 276,
Feijoo, C., Hall-Jackson, C., Wu, R., Jenkins, D., Leitch, J., Gilbert, D.M., 26656–26665.
and Smythe, C. (2001). Activation of mammalian Chk1 during DNA replication
arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication Nghiem, P., Park, P.K., Kim, Y., Vaziri, C., and Schreiber, S.L. (2001). ATR
inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal prema-origin firing. J. Cell Biol. 154, 913–923.
ture chromatin condensation. Proc. Natl. Acad. Sci. USA 98, 9092–9097.
Gasparotto, D., Maestro, R., Piccinin, S., Vukosavljevic, T., Barzan, L., Sul-
faro, S., and Boiocchi, M. (1997). Overexpression of CDC25A and CDC25B Rajan, J.V., Wang, M., Marquis, S.T., and Chodosh, L.A. (1996). Brca2 is
coordinately regulated with Brca1 during proliferation and differentiation inin head and neck cancers. Cancer Res. 57, 2366–2368.
mammary epithelial cells. Proc. Natl. Acad. Sci. USA 93, 13078–13083.
Gentile, M., Olsen, K., Dufmats, M., and Wingren, S. (1999). Frequent allelic
losses at 11q24.1-q25 in young women with breast cancer: association with Rijnkels, M., and Rosen, J.M. (2001). Adenovirus-Cre-mediated recombina-
tion in mammary epithelial early progenitor cells. J. Cell Sci. 114, 3147–3153.poor survival. Br. J. Cancer 80, 843–849.
Goepfert, T.M., McCarthy, M., Kittrell, F.S., Stephens, C., Ullrich, R.L., Brink- Rocha, B., Penit, C., Baron, C., Vasseur, F., Dautigny, N., and Freitas, A.A.
(1990). Accumulation of bromodeoxyuridine-labeled cells in central and pe-ley, B.R., and Medina, D. (2000). Progesterone facilitates chromosome insta-
bility (aneuploidy) in p53 null normal mammary epithelial cells. FASEB J. 14, ripheral lymphoid organs: Minimal estimates of production and turnover
rates of mature lymphocytes. Eur. J. Immunol. 20, 1697–1708.2221–2229.
Goto, H., Yasui, Y., Nigg, E.A., and Inagaki, M. (2002). Aurora-B phosphory- Rogakou, E.P., Nieves-Neira, W., Boon, C., Pommier, Y., and Bonner, W.M.
(2000). Initiation of DNA fragmentation during apoptosis induces phosphory-lates Histone H3 at serine28 with regard to the mitotic chromosome conden-
sation. Genes Cells 7, 11–17. lation of H2AX histone at serine 139. J. Biol. Chem. 275, 9390–9395.
Said, T.K., and Medina, D. (1995). Cell cyclins and cyclin-dependent kinaseGudmundsson, J., Barkardottir, R.B., Eiriksdottir, G., Baldursson, T., Arason,
A., Egilsson, V., and Ingvarsson, S. (1995). Loss of heterozygosity at chromo- activities in mouse mammary tumor development. Carcinogenesis 16, 823–
830.some 11 in breast cancer: association of prognostic factors with genetic
alterations. Br. J. Cancer 72, 696–701.
Sanchez, Y., Wong, C., Thoma, R.S., Richman, R., Wu, Z., Piwnica-Worms,
H., and Elledge, S.J. (1997). Conservation of the Chk1 checkpoint pathwayHapke, G., Yin, M.B., and Rustum, Y.M. (2001). Targeting molecular signals
in chk1 pathways as a new approach for overcoming drug resistance. Cancer in mammals: Linkage of DNA damage to Cdk regulation through Cdc25.
Science 277, 1497–1501.Metastasis Rev. 20, 109–115.
Jin, P., Gu, Y., and Morgan, D.O. (1996). Role of inhibitory CDC2 phosphory- Schultz, L.B., Chehab, N.H., Malikzay, A., and Halazonetis, T.D. (2000). p53
binding protein 1 (53BP1) is an early participant in the cellular response tolation in radiation-induced G2 arrest in human cells. J. Cell Biol. 134, 963–
970. DNA double-strand breaks. J. Cell Biol. 151, 1381–1390.
Sheaff, R.J., Groudine, M., Gordon, M., Roberts, J.M., and Clurman, B.E.Kriss, J.P., and Revesz, L. (1962). The distribution and fate of bromodeoxyuri-
dine and bromodeoxycytidine in the mouse and rat. Cancer Res. 22, 254– (1997). Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11, 1464–1478.
265.
Sogo, J.M., Lopes, M., and Foiani, M. (2002). Fork reversal and ssDNA
accumulation at stalled replication forks owing to checkpoint defects. Sci-Launonen, V., Stenback, F., Puistola, U., Bloigu, R., Huusko, P., Kytola, S.,
Kauppila, A., and Winqvist, R. (1998). Chromosome 11q22.3-q25 LOH in ence 297, 599–602.
ovarian cancer: association with a more aggressive disease course and
Sorensen, C.S., Syljuasen, R.G., Falck, J., Schroeder, T., Ronnstrand, L.,involved subregions. Gynecol. Oncol. 71, 299–304.
Khanna, K.K., Zhou, B.B., Bartek, J., and Lukas, J. (2003). Chk1 regulates
the S phase checkpoint by coupling the physiological turnover and ionizingLee, J., Kumagai, A., and Dunphy, W.G. (2003). Claspin, a Chk1-regulatory
protein, monitors DNA replication on chromatin independently of RPA, ATR, radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 3, 247–
258.and Rad17. Mol. Cell 11, 329–340.
Li, Q., and Zhu, G.D. (2002). Targeting serine/threonine protein kinase B/Akt Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre re-
porter strain. Nat. Genet. 21, 70–71.and cell-cycle checkpoint kinases for treating cancer. Curr. Top. Med. Chem.
2, 939–971.
Stewart, G.S., Wang, B., Bignell, C.R., Taylor, A.M., and Elledge, S.J. (2003).
MDC1 is a mediator of the mammalian DNA damage checkpoint. NatureLiu, Q., Guntuku, S., Cui, X.S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G.,
Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000). Chk1 is an essential 421, 961–966.
kinase that is regulated by Atr and required for the G(2)/M DNA damage
Sugiyama, K., Sugiura, K., Hara, T., Sugimoto, K., Shima, H., Honda, K.,checkpoint. Genes Dev. 14, 1448–1459.
Furukawa, K., Yamashita, S., and Urano, T. (2002). Aurora-B associated
protein phosphatases as negative regulators of kinase activation. OncogeneMailand, N., Falck, J., Lukas, C., Syljuasen, R.G., Welcker, M., Bartek, J.,
and Lukas, J. (2000). Rapid destruction of human Cdc25A in response to 21, 3103–3111.
DNA damage. Science 288, 1425–1429.
Takai, H., Tominaga, K., Motoyama, N., Minamishima, Y.A., Nagahama, H.,
Tsukiyama, T., Ikeda, K., Nakayama, K., and Nakanishi, M. (2000). AberrantMcKinstry, R., Qiao, L., Yacoub, A., Dai, Y., Decker, R., Holt, S., Hagan,
M.P., Grant, S., and Dent, P. (2002). Inhibitors of MEK1/2 interact with cell cycle checkpoint function and early embryonic death in Chk1(/) mice.
Genes Dev. 14, 1439–1447.UCN-01 to induce apoptosis and reduce colony formation in mammary and
prostate carcinoma cells. Cancer Biol. Ther. 1, 243–253.
Terada, Y., Tatsuka, M., Suzuki, F., Yasuda, Y., Fujita, S., and Otsu, M. (1998).
AIM-1: A mammalian midbody-associated protein required for cytokinesis.Menoyo, A., Alazzouzi, H., Espin, E., Armengol, M., Yamamoto, H., and
Schwartz, S., Jr. (2001). Somatic mutations in the DNA damage-response EMBO J. 17, 667–676.
genes ATR and CHK1 in sporadic stomach tumors with microsatellite insta-
Vigo, E., Muller, H., Prosperini, E., Hateboer, G., Cartwright, P., Moroni,bility. Cancer Res. 61, 7727–7730.
M.C., and Helin, K. (1999). CDC25A phosphatase is a target of E2F and is
required for efficient E2F-induced S phase. Mol. Cell. Biol. 19, 6379–6395.Molinari, M., Mercurio, C., Dominguez, J., Goubin, F., and Draetta, G.F.
(2000). Human Cdc25 A inactivation in response to S phase inhibition and
Wagner, K.U., Wall, R.J., St-Onge, L., Gruss, P., Wynshaw-Boris, A., Garrett,its role in preventing premature mitosis. EMBO Rep. 1, 71–79.
L., Li, M., Furth, P.A., and Hennighausen, L. (1997a). Cre-mediated gene
deletion in the mammary gland. Nucleic Acids Res. 25, 4323–4330.Moroi, Y., Peebles, C., Fritzler, M.J., Steigerwald, J., and Tan, E.M. (1980).
58 CANCER CELL : JULY 2004
A R T I C L E
Wagner, K.U., Young, W.S., 3rd, Liu, X., Ginns, E.I., Li, M., Furth, P.A., and Zachos, G., Rainey, M.D., and Gillespie, D.A. (2003). Chk1-deficient tumour
cells are viable but exhibit multiple checkpoint and survival defects. EMBOHennighausen, L. (1997b). Oxytocin and milk removal are required for post-
J. 22, 713–723.partum mammary-gland development. Genes Funct. 1, 233–244.
Zhao, H., Watkins, J.L., and Piwnica-Worms, H. (2002). Disruption of theWagner, K.U., Boulanger, C.A., Henry, M.D., Sgagias, M., Hennighausen,
checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radia-L., and Smith, G.H. (2002). An adjunct mammary epithelial cell population
tion-induced S and G2 checkpoints. Proc. Natl. Acad. Sci. USA 99, 14795–in parous females: its role in functional adaptation and tissue renewal. Devel-
14800.opment 129, 1377–1386.
Zhou, B.B., and Sausville, E.A. (2003). Drug discovery targeting Chk1 andWu, W., Fan, Y.H., Kemp, B.L., Walsh, G., and Mao, L. (1998). Overexpres-
Chk2 kinases. Prog. Cell Cycle Res. 5, 413–421.
sion of cdc25A and cdc25B is frequent in primary non-small cell lung cancer
but is not associated with overexpression of c-myc. Cancer Res. 58, 4082– Zhou, B.B., Anderson, H.J., and Roberge, M. (2003). Targeting DNA check-
point kinases in cancer therapy. Cancer Biol. Ther. 2, S16–S22.4085.
CANCER CELL : JULY 2004 59
